U.S. lawmakers tussle over generic biologic drugs

June 12, 2009

U.S. lawmakers tussled on Thursday over how long makers of biotechnology drugs should have an exclusive license for the expensive medicines in a hearing called to discuss a Federal Trade Commission report on the issue. (Reuters)